Please use this identifier to cite or link to this item:
Title: BAK and NOXA are critical determinants of mitochondrial apoptosis induced by bortezomib in mesothelioma.
Authors: Busacca, Sara
Chacko, A. D.
Klabatsa, A.
Arthur, K.
Sheaff, M.
Barbone, D.
Mutti, L.
Gunasekharan, V. K.
Gorski, J. J.
El-Tanani, M.
Broaddus, V. C.
Gaudino, G.
Fennell, Dean A.
First Published: 7-Jun-2013
Publisher: Public Library of Science
Citation: PLoS One, 2013, 8 (6), e65489
Abstract: Based on promising preclinical efficacy associated with the 20S proteasome inhibitor bortezomib in malignant pleural mesothelioma (MPM), two phase II clinical trials have been initiated (EORTC 08052 and ICORG 05-10). However, the potential mechanisms underlying resistance to this targeted drug in MPM are still unknown. Functional genetic analyses were conducted to determine the key mitochondrial apoptotic regulators required for bortezomib sensitivity and to establish how their dysregulation may confer resistance. The multidomain proapoptotic protein BAK, but not its orthologue BAX, was found to be essential for bortezomib-induced apoptosis in MPM cell lines. Immunohistochemistry was performed on tissues from the ICORG-05 phase II trial and a TMA of archived mesotheliomas. Loss of BAK was found in 39% of specimens and loss of both BAX/BAK in 37% of samples. However, MPM tissues from patients who failed to respond to bortezomib and MPM cell lines selected for resistance to bortezomib conserved BAK expression. In contrast, c-Myc dependent transactivation of NOXA was abrogated in the resistant cell lines. In summary, the block of mitochondrial apoptosis is a limiting factor for achieving efficacy of bortezomib in MPM, and the observed loss of BAK expression or NOXA transactivation may be relevant mechanisms of resistance in the clinic.
DOI Link: 10.1371/journal.pone.0065489
eISSN: 1932-6203
Version: Publisher Version
Status: Peer-reviewed
Type: Journal Article
Rights: Copyright © 2013 Busacca et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Appears in Collections:Published Articles, Dept. of Cancer Studies and Molecular Medicine

Files in This Item:
File Description SizeFormat 
BAK and NOXA are critical determinants of mitochondrial apoptosis induced by bortezomib in mesothelioma..pdfPublished (publisher PDF)2.19 MBAdobe PDFView/Open

Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.